Suzhou Zelgen Biopharmaceuticals Co., Ltd. Price (688266.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

255,580,499

(6.4919)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
news-img

Income Statement

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Currency: CNY

YEAR 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 200,334.00

+0%

0.00

+0%

1,311,158.00

+0%

0.00

+0%

27,660,909.00

+0%

190,360,565.00

+588%

302,305,057.00

+59%

386,438,784.00

+28%

Cost of Revenue
Cost of Revenue 159,800.00 5,087,100.00 893,903.00 33,268,210.00 27,476.00 6,268,583.00 26,161,022.00 31,422,727.00
Gross Profit
Gross Profit 40,534.00

+0%

-5,087,100.00

-12,650%

417,255.00

-108%

-33,268,210.00

-8,073%

27,633,433.00

-183%

184,091,982.00

+566%

276,144,035.00

+50%

355,016,057.00

+29%

Gross Profit Ratio (0.20%) (0.00%) (0.32%) (0.00%) (1.00%) (0.97%) (0.91%) (0.92%)
Operating Expenses
Research and Development 61,077,401.00 158,822,535.00 142,805,223.00 183,841,536.00 314,198,309.00 509,394,274.00 497,725,871.00 496,329,685.00
General and Administrative 73,625,837.00 7,576,050.00 312,602,103.00 246,940,869.00 43,227,145.00 51,605,502.00 53,889,193.00 -18,100,168.58
Selling, General & Admin... 73,625,837.00 7,576,050.00 312,602,103.00 254,770,768.00 78,297,105.00 191,347,995.00 281,574,541.00 100,410,308.00
Selling & Marketing Exp... 0.00 0.00 0.00 7,829,898.00 35,069,959.00 139,742,493.00 227,685,348.00 119,404,732.00
Depreciation and Amortiz... 5,733,200.00 5,087,100.00 14,083,000.00 33,268,210.00 46,704,140.00 53,393,010.00 70,806,070.00 54,829,798.00
Other Expenses 5,365,137.00 -1,149.93 -10,000.00 1,655,602.00 -6,826,365.78 -14,019,368.87 666,993.00 0.00
Total Operating Expenses 134,966,312.00 148,326,096.00 446,101,491.00 440,267,907.00 385,669,049.00 686,722,901.00 779,967,406.00 652,798,454.00
Cost and Exponses 135,126,113.00 148,326,096.00 446,995,394.00 440,267,907.00 385,696,525.00 692,991,485.00 806,128,429.00 684,221,182.00
Operating Income
Operating Income -133,633,005.56

+0%

-146,467,298.13

+10%

-442,647,860.70

+202%

-439,788,510.54

-1%

-358,035,616.39

-19%

-502,630,919.49

+40%

-503,823,371.70

+0%

-408,794,850.00

-19%

Operating Income Ratio (-667.05%) (0.00%) (-337.60%) (0.00%) (-12.94%) (-2.64%) (-1.67%) (-1.06%)
Other Income and Exp...
Interest Income 1,290,520.00 1,931,145.00 879,366.00 1,167,194.00 38,339,607.00 39,977,624.00 28,745,441.00 39,354,994.00
Interest Expenses 0.00 0.00 30,612.00 1,159,999.00 1,088,146.00 4,417,201.00 12,031,551.00 24,451,686.00
Total Other Income/Exp... 5,365,137.00 -1,150.06 -10,000.00 906.54 -4,576.00 -6,102,926.00 -2,397,235.00 109,710,339.00
EBITDA
EBITDA -129,192,571.66 -141,381,343.00 -437,351,347.40 -405,002,339.00 -256,629,539.00 -405,553,834.00 -402,207,120.00 -214,226,485.00
EBITDA ratio (-644.66%) (0.00%) (-329.35%) (0.00%) (-9.90%) (-2.14%) (-1.36%) (-0.55%)
Income Before Tax
Income Before Tax -128,267,868.56 -146,468,448.06 -442,657,860.70 -439,787,607.29 -304,832,774.03 -465,147,215.39 -487,954,729.84 -299,084,511.00
Income Before Tax Ratio (-640.27%) (0.00%) (-337.61%) (0.00%) (-11.02%) (-2.44%) (-1.61%) (-0.77%)
Income Tax Expense
Income Tax Expense 44,318.00 -56,989.58 -780,375.50 8,195,956.00 5,842,563.00 -3,156,392.88 -2,005,371.74 -3,949,557.00
Net Income
Net Income -128,267,868.56

+0%

-146,468,448.06

+14%

-440,089,014.69

+200%

-447,983,564.07

+2%

-310,675,338.01

-31%

-461,990,822.51

+49%

-485,949,358.10

+5%

-278,582,744.00

-43%

Net Income Ratio (-640.27%) (0.00%) (-335.65%) (0.00%) (-11.23%) (-2.43%) (-1.61%) (-0.72%)
Earning Per Share
Basic EPS -0.71 -0.81 -2.45 -1.87 -1.29 -1.92 -2.02 -1.09
Diluted EPS -0.71 -0.81 -2.45 -1.87 -1.29 -1.92 -2.02 -1.09
Share Outstanding
Basic Share Outstanding 179,718,770.00 179,718,770.00 179,718,770.00 240,000,000.00 240,000,000.00 240,000,000.00 240,000,000.00 255,580,499.00
Diluted Share Outstanding 179,718,770.00 179,718,770.00 179,718,770.00 240,000,000.00 240,000,000.00 240,000,000.00 240,000,000.00 255,580,499.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation